Characteristics of Dupilumab-Treated Patients with Atopic Dermatitis Over Time: A Cross-Sectional Assessment of Potential Channeling Bias upon Pediatric Label Extension

Dermatology and Therapy · Published 2026-07-18 · DOI 10.1007/s13555-026-01859-y

Free full text

Authors (5)

Julie Barberio, Venkatesh Harikrishnan, Shiyao Gao, Andrea Marcus, Sarah-Jo Sinnott

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Barberio, J., Harikrishnan, V., Gao, S., et al. (2026). Characteristics of Dupilumab-Treated Patients with Atopic Dermatitis Over Time: A Cross-Sectional Assessment of Potential Channeling Bias upon Pediatric Label Extension. Dermatology and Therapy. https://doi.org/10.1007/s13555-026-01859-y

Related articles

• Consensus Recommendations for Management of Darier Disease: A Practical Approach · Dermatology and Therapy · 2026 · Same journal
• Effectiveness, Safety, and Drug Survival of Bimekizumab in Chronic Plaque Psoriasis over 2 Years: Real-World Experience from Northern Italy · Dermatology and Therapy · 2026 · Same journal
• Patient Preferences for Treatment Attributes in Moderate to Severe Chronic Hand Eczema: A Discrete Choice Experiment · Dermatology and Therapy · 2026 · Same journal
• JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study · Dermatology and Therapy · 2026 · Same journal
• Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo · Dermatology and Therapy · 2026 · Same journal
• Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study · Dermatology and Therapy · 2026 · Same journal
• Itch, Scratching, and Sleep Mediate the Association between Disease Severity and Quality of Life in Pruritic Dermatoses: A Cross-Sectional Study · Dermatology and Therapy · 2026 · Same journal
• Efficacy of Upadacitinib in Patients with Atopic Dermatitis of the Head and Neck Region · Dermatology and Therapy · 2026 · Same journal
• Immunobiological Therapy in Moderate-to-Severe Psoriasis: A Retrospective Cohort Study Investigating the Effects of Inadequate Therapeutic Compliance on Drug Survival · Dermatology and Therapy · 2026 · Same journal
• Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area · Dermatology and Therapy · 2026 · Same journal